Identification of Leishmania donovani PEX5-PTS1 Interaction Inhibitors through Fluorescence Polarization-Based High-Throughput Screening
Open Access
Abstract
Leishmaniasis, an infectious disease caused by pathogenic Leishmania parasites, affects millions of people in developing countries, and its re-emergence in developed countries, particularly in Europe, poses a growing public health concern. The limitations of current treatments and the absence of effective vaccines necessitate the development of novel therapeutics. In this study, we focused on identifying small molecule inhibitors which prevents the interaction between peroxin 5 (PEX5) and peroxisomal targeting signal 1 (PTS1), pivotal for kinetoplastid parasite survival. The Leishmania donovani PEX5, containing a C-terminal tetratricopeptide repeat (TPR) domain, was expressed and purified, followed by the quantification of kinetic parameters of PEX5-PTS1 interactions. A fluorescence polarization-based high-throughput screening assay was developed and small molecules inhibiting the LdPEX5-PTS1 interaction were discovered through the screening of a library of 51,406 compounds. Based on the confirmatory assay, nine compounds showed half maximal inhibitory concentration (IC50) values ranging from 3.89 to 24.50 µM. In silico docking using a homology model of LdPEX5 elucidated that the molecular interactions between LdPEX5 and the inhibitors share amino acids critical for PTS1 binding. Notably, compound P20 showed potent activity against the growth of L. donovani promastigotes, L. major promastigotes, and Trypanosoma brucei blood stream form, with IC50 values of 12.16, 19.21, and 3.06 μM, respectively. The findings underscore the potential of targeting LdPEX5-PTS1 interactions with small molecule inhibitors as a promising strategy for the discovery of new anti-parasitic compounds.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2023M3A9G6057281)
- National Research Foundation of Korea (NRF-2023M3A9G6057281)
This publication has 32 references indexed in Scilit:
- Development of novel PEX5-PEX14 protein-protein interaction (PPI) inhibitors based on an oxopiperazine templateEuropean Journal of Medicinal Chemistry, 2023
- Discovery of novel Leishmania major trypanothione synthetase inhibitors by high-throughput screeningBiochemical and Biophysical Research Communications, 2022
- A Review of Leishmaniasis: Current Knowledge and Future DirectionsCurrent Tropical Medicine Reports, 2021
- Biogenesis, maintenance and dynamics of glycosomes in trypanosomatid parasitesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2016
- Visceral leishmaniasis: Revisiting current treatments and approaches for future discoveriesActa Tropica, 2016
- Amphotericin B Formulations: A Comparative Review of Efficacy and ToxicityDrugs, 2013
- Characterization of the role of the receptors PEX5 and PEX7 in the import of proteins into glycosomes of Trypanosoma bruceiBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Peroxisome targeting signal 1: Is it really a simple tripeptide?Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2006
- The glycosome of trypanosomes: Properties and biogenesis of a microbodyExperimental Parasitology, 1989
- Biogenesis of the glycosome in Trypanosoma brucei: the synthesis, translocation and turnover of glycosomal polypeptides.The EMBO Journal, 1987